e-learning
resources
Virtual 2021
08.09.2021
Different treatment modalities and impact of comorbidities on sleep disordered breathing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial
Y. Peker (Istanbul, Turkey), M. Saygin (Isparta, Turkey), E. Thunström (Gothenburg, Sweden), P. J Strollo Jr (Pittsburgh, United States of America)
Source:
Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Session:
Different treatment modalities and impact of comorbidities on sleep disordered breathing
Session type:
Oral Presentation
Number:
4388
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Peker (Istanbul, Turkey), M. Saygin (Isparta, Turkey), E. Thunström (Gothenburg, Sweden), P. J Strollo Jr (Pittsburgh, United States of America). Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial. 4388
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021
Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP
Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017
Year: 2017
Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort
Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Year: 2020
Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up
Source: Eur Respir J 2006; 28: 596-602
Year: 2006
Increased incidence of coronary artery disease in obstructive sleep apnoea: a seven-year follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001
Influence of obstructive sleep apnea in coronary artery disease: an 8-years-follow-up
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003
Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009
Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018
Late Breaking Abstract: Baseline characteristics of the revascularized patients with coronary artery disease and obstructive sleep apnoea in the RICCADSA trial
Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research
Year: 2010
Late-breaking abstract: Cardiac function in a revascularized coronary artery disease cohort with obstructive sleep apnoea with and without daytime sleepiness in the RICCADSA trial
Source: Annual Congress 2011 - Obstructive sleep apnoea in children and adults
Year: 2011
CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017
Depression and response to CPAP treatment in coronary artery disease patients with sleepy vs nonsleepy obstructive slee apnoea
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018
Obstructive sleep apnoea and coronary artery disease
Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities
Year: 2016
Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA).
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017
Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease
Source: International Congress 2017 – CPAP therapy
Year: 2017
Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007
Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept